I am still skeptical about low level laser therapy (LLLT) for hair regrowth. However, it seems like these lasers are not causing any bad side effects, and each year brings brings new products into the market.
Theradome has been getting especially frequent coverage by the media of late. The company has just published new videos on its Youtube channel.
Theradome also garnered good publicity this month via a Bloomberg article on Theradome and its CEO.
Leonard from HairMax LaserComb posted the below comment under my older LLLT post and I thought it deserved its own post. I still find it hard to believe that lasers can do anything substantial for your hair, but hopefully we will get far more evidence for or against LLLT in the future. At the moment, there are very few well designed unaffiliated studies concerning LLLT out there.
I am Leonard Stillman, Director of Professional Services at Lexington International, LLC, manufacturers of the HairMax LaserComb. This post is NOT for commercial purposes, but is to notify your readers of a landmark clinical paper that was published in January 2014, in a peer-review medical journal. The article provides complete information on 4 studies with 225 subjects, which conclusively proved the efficacy and safety of the HairMax LaserComb in treating male and female pattern hair loss.
The article is titled: Efficacy and Safety of a Low-level Laser Device in the Treatment of Male and Female Pattern Hair Loss: A Multicenter, Randomized, Sham Device-controlled, Double-blind Study.
Low level laser therapy (LLLT) may provide an alternative treatment option for patients who do not respond to either finasteride or minoxidil. Moreover, topical minoxidil (solution or foam) needs to be applied once or twice daily. It also has to be in contact with the scalp for at least 4 hours. Such an application protocol may be impractical for many users.
In contrast, the HairMax lasercomb treatment just requires 8–15 minutes of treatment, three times per week. Such a user friendly approach will lead to better patient compliance and, subsequently, improved efficacy.